MissionIR News – Seeking Alpha Publishes Article Featuring Cardium Therapeutics

Share Article

Author tells investors to take a look at nutritional supplement stocks

Cardium is unique in that the company not only offers a growing nutraceutical product line focused on the millennial consumer, but is also developing regenerative medicine products, making it attractive from multiple directions.

MissionIR would like to highlight Cardium Therapeutics, Inc. (NYSE MKT: CXM), a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs that have definable pathways to commercialization, partnering, and other economic monetizations.

Seeking Alpha recently published the following article featuring Cardium Therapeutics as one of the focus tickers: http://seekingalpha.com/article/719941

Seeking Alpha handpicks articles from the world’s top market blogs, money managers, financial experts, and investment newsletters – publishing approximately 250 articles daily. Boasting more than 1 million members, the website has a strong readership among money managers, research analysts, investment bankers, and serious individual investors.

With the U.S. economy growing at an anemic 2 percent, there’s one industry that does not have iron poor blood. Niche markets within the larger vitamin and supplement industry are on fire, with some reaching double-digit growth. Although the overall supplements market has been affected by the sluggish economy and occasional regulation issues, it continues to outpace the economy, with hot offerings such as antioxidants and fish oil getting major boosts every time a news story or afternoon doctors’ show gives them a thumbs-up.

While the classic nutraceutical business has focused on "baby boomers", Cardium's MedPodium product line is designed to speak to the millennial consumer (aged 20-35). Baby boomers typically purchase products to address issues relating to heart disease, diabetes, and joint health, while millennial consumers seek out products for energy, relaxation, and aesthetics. Cardium's MedPodium Nutra-Apps products feature Neo-Energy, Neo-Carb-Bloc, and Neo-Chill that provide premium ingredients that have been characterized scientifically and shown to support the active lifestyles of millennials. These Nutra-Apps are small, pharmaceutically-sealed, tasteless, easy-use capsules that come in pocket-sized "one-and-done" servings. Unlike the other nutraceutical companies featured in the article, Cardium is unique in that the company not only offers a growing nutraceutical product line focused on the millennial consumer, but is also developing regenerative medicine products, making it attractive from multiple directions.

About MissionIR

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

To sign up for The MissionIR Report, please visit http://MissionIR.com

To connect with MissionIR via Facebook, please visit http://Facebook.com/MissionIR

To connect with MissionIR via Twitter, please visit http://Twitter.com/MissionIR

Please read FULL disclaimer on the MissionIR website: http://Disclaimer.MissionIR.com

Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

MissionIR Communications
Visit website